{"id":"dwj1319","safety":{"commonSideEffects":[{"rate":null,"effect":"Testosterone suppression"},{"rate":null,"effect":"Liver enzyme elevation"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"SARMs like DWJ1319 are designed to selectively activate androgen receptors in muscle and bone tissue while avoiding activation in prostate and other tissues that mediate unwanted androgenic effects. This tissue selectivity aims to provide anabolic benefits such as increased muscle mass and bone density with a reduced side effect profile compared to traditional androgens or anabolic steroids.","oneSentence":"DWJ1319 is a selective androgen receptor modulator (SARM) that binds to androgen receptors to promote anabolic effects while minimizing androgenic side effects.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:10:25.131Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Muscle wasting or sarcopenia (phase 3 development)"}]},"trialDetails":[{"nctId":"NCT02490111","phase":"PHASE3","title":"Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2015-05","conditions":"Gastric Cancer","enrollment":521}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"DWJ1319","genericName":"DWJ1319","companyName":"Daewoong Pharmaceutical Co. LTD.","companyId":"daewoong-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DWJ1319 is a selective androgen receptor modulator (SARM) that binds to androgen receptors to promote anabolic effects while minimizing androgenic side effects. Used for Muscle wasting or sarcopenia (phase 3 development).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}